NXTC - NextCure  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NXTC is currently covered by 2 analysts with an average price target of $36.33. This is a potential upside of $22.74 (167.33%) from yesterday's end of day stock price of $13.59.

NextCure 's activity chart (see below) currently has 44 price targets and 46 ratings on display. The stock rating distribution of NXTC is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 45.99% with an average time for these price targets to be met of 140.89 days.

Highest price target for NXTC is $15, Lowest price target is $15, average price target is $15.

Most recent stock forecast was given by EDWARD TENTHOFF from PIPER SANDLER on 15-Jul-2025. First documented stock forecast 03-Jun-2019.

Currently out of the existing stock ratings of NXTC, 4 are a BUY (100%).

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

Since 03-Jun-2019

$15

$1.72 (12.95%)

$13

5 months 25 days ago
(15-Jul-2025)

8/9 (88.89%)

$10.24 (215.13%)

298

Buy

Since 08-Aug-2023

$36

6 months 8 days ago
(01-Jul-2025)

0/3 (0%)

$28.31 (368.14%)

Buy

Since 05-Nov-2021

$4

$-9.28 (-69.88%)

$72

1 years 5 months 7 days ago
(02-Aug-2024)

1/4 (25%)

$-15.2 (-79.17%)

249

Hold

Since 04-Nov-2022

$192

3 years 2 months 5 days ago
(04-Nov-2022)

0/3 (0%)

$132.96 (225.20%)

Buy

Since 13-Jan-2020

$15

$1.72 (12.95%)

$228

3 years 4 months 17 days ago
(23-Aug-2022)

2/4 (50%)

$-38.28 (-71.85%)

152

Show more analysts

Please expand the browser size to see the chart

What is NXTC (NextCure ) average time for price targets to be met?

On average it took 140.89 days on average for the stock forecasts to be realized with a an average price target met ratio 45.99

Which analyst has the current highest performing score on NXTC (NextCure ) with a proven track record?

EDWARD TENTHOFF

Which analyst has the current lower performing score on NXTC (NextCure ) with a proven track record?

ROBERT HAZLETT

Which analyst has the most public recommendations on NXTC (NextCure )?

Edward Tenthoff works at PIPER SANDLER and has 5 price targets and 4 ratings on NXTC

Which analyst is the currently most bullish on NXTC (NextCure )?

Chad Messer with highest potential upside - $154.72

Which analyst is the currently most reserved on NXTC (NextCure )?

Gil Blum with lowest potential downside - -$9.28

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?